520 results
Page 5 of 26
8-K
EX-99.1
goinnu
11 Jan 21
Regulation FD Disclosure
4:07pm
8-K
EX-99.1
uox06ky6sbli
14 Dec 20
Regulation FD Disclosure
8:04am
8-K
EX-99.2
zgwdux82loazvu
14 Dec 20
Regulation FD Disclosure
8:04am
8-K
EX-99.1
da6pk9 ru2r7p4
17 Nov 20
Caladrius Biosciences Announces the Resignation of Dr. Douglas Losordo, Chief Medical Officer
4:06pm
8-K
EX-99.1
s9wzlhoh vcqwos1
5 Nov 20
Caladrius Biosciences Provides Corporate Update and Reports 2020 Third Quarter Financial Results
4:09pm
8-K
EX-99.1
15gsuyf6pjz05tho
13 Aug 20
Caladrius Biosciences Provides Corporate Update and Reports 2020 Second Quarter Financial Results
4:08pm
8-K
EX-10.2
183 qcpox20h94
10 Jul 20
Entry into a Material Definitive Agreement
4:41pm
8-K
EX-10.1
no4zggysagkmq l8
10 Jul 20
Entry into a Material Definitive Agreement
4:41pm
424B5
96ykv9sc5fsg9yviof
26 May 20
Prospectus supplement for primary offering
4:02pm
8-K
EX-10.1
1tsfu 1utfvib84th2
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am
8-K
EX-10.2
10i rf21qdvz35
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am
8-K
EX-99.1
oakz9f0
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am
8-K
EX-99.1
jwtc9zl d8p5r9l9hf7g
7 May 20
Caladrius Biosciences Provides Corporate Update and Reports 2020 First Quarter Financial Results
4:09pm
424B5
lxqxz4qt2nlhkuv7dbu7
27 Apr 20
Prospectus supplement for primary offering
7:30am
8-K
EX-10.1
sywxb
24 Apr 20
Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:02pm
8-K
EX-99.1
ix65onqcjj9axkzwhtu
24 Apr 20
Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:02pm
8-K
EX-10.2
odanxs0ml3
24 Apr 20
Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:02pm
8-K
EX-99.1
qpf5nuna
5 Mar 20
Caladrius Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
4:07pm